Scopolamine For The Treatment Of Depression And Anxiety
United Kingdom
06760136.9
Filed on 2006-05-18
06760136.9
Filed on 2006-05-18
Scopolamine For The Treatment Of Depression And Anxiety
France
06760136.9
Filed on 2006-05-18
06760136.9
Filed on 2006-05-18
Scopolamine For The Treatment Of Depression And Anxiety
Germany
06760136.9
Filed on 2006-05-18
06760136.9
Filed on 2006-05-18
SCHIZOPHRENIA-RELATED ISOFORM OF KCNH2 AND DEVELOPMENT OF ANTIPSYCHOTIC DRUGS
US Patent 8,871,443
Filed on 2012-01-24
Filed on 2012-01-24
Phosphatidylinositol-3-Kinase P110 Delta-Targeted Drugs In The Treatments Of CNS Disorders
US Application 13/132,425
Filed on 2011-08-17
Filed on 2011-08-17
Drugs That Target PIK3CD Are Effective Treatments Of Schizophrenia, Psychosis, And Cognitive Deficiency
European Patent
09771628.6
Filed on 2009-12-04
09771628.6
Filed on 2009-12-04
Phosphatidylinositol-3-kinase p110 delta-Targeted Drugs in the Treatment of CNS Disorders
Canada
2745280
Filed on 2009-12-04
2745280
Filed on 2009-12-04
Phosphatidylinositol-3-kinase p110 delta-Targeted Drugs in the Treatment of CNS Disorders
Australia
2009322187
Filed on 2009-12-04
2009322187
Filed on 2009-12-04
IMMUNOTOXINS FUSION PROTEINS AND MEANS FOR EXPRESSION THEREOF
US Patent 8,987,426
Filed on 2012-04-10
Filed on 2012-04-10
Methods for Expression and Purification of Immunotoxins
India
8736/DELNP/2011
Filed on 2004-08-02
8736/DELNP/2011
Filed on 2004-08-02